Key diabetes opinion leader: Staggering $3T annual cost of chronic conditions in U.S., largely preventable
July 28, 2020
Digital therapeutics provide unprecedented opportunity to cure U.S. chronic illness like diabetes, hypertension, and depression
Fascinating discussion with leading diabetes expert, Dr. David Simmons, M.D. former chief medical officer of Bayer and Ascensia in the video below.
More than even genetic disposition, behavior is far and away the most influential factor in chronic illness. Fix behavior, reduce illness
Genetics doubled risk for chronic disease but behavior multiplies 6x.
Despite a surge in medication commercialization, chronic illnesses like diabetes and hypertension remain out of control
Key to success in combating chronic illness is personalization
Current healthcare system doesn't allow scale AND personalization until digital therapeutics.
Check out the full discussion in the video below. 06:00 is where the meat of it commences.
Latest product video from DarioHealth reveals the competitive advantage they plan to leverage in a strategic pivot from exclusively B2C to the B2B digital health market of self insured employers, health plans, and healthcare providers.
Addition adds nearly 30 years of senior health plan leadership expertise to the company's Board